Update: A Revolution in the Treatment of Non-Hodgkin's Lymphoma

Abstract
The use of monoclonal antibodies (MoAbs) for immunotherapy and radioimmunotherapy has ushered in a new era in the treatment of non-Hodgkin's lymphoma.